INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
Rhea-AI Summary
INOVIO (NASDAQ: INO), a biotechnology company focused on DNA medicines for HPV-associated diseases, cancer, and infectious diseases, announced it will release its third quarter 2024 financial results after market close on November 14, 2024. The company will host a conference call and webcast at 4:30 p.m. ET on the same day, featuring a Q&A session with analysts. The webcast will be accessible at the company's investor relations website and will remain available for replay for 90 days.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, INO gained 0.89%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2024-financial-results-on-november-14-2024-302297260.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When will INOVIO (INO) release Q3 2024 earnings?
What time is INOVIO's (INO) Q3 2024 earnings call?
How long will INOVIO's (INO) Q3 2024 earnings webcast be available for replay?
